Your session is about to expire
← Back to Search
Blueberry Powder for Infant Development
Study Summary
This trial will study the effects of blueberries on gut microbiota, inflammation and immunity in breastfed infants.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are researchers currently accepting participants for this investigation?
"Clinicaltrials.gov data reveals that this investigation is currently recruiting participants. It was initially advertised on the 1st of September 2021 and its latest update occurred a week later, on the 8th day of that month."
What is the current scope of participation in this scientific experiment?
"Affirmative. Clinicaltrials.gov has the latest information on this trial, which was published for public scrutiny on September 1st 2021 and updated lastly on the 8th of same month; it is presently recruiting 152 patients from a single facility."
What are the eligibility criteria for participation in this clinical investigation?
"This clinical trial will admit 152 infants aged 4-5 Months. The primary requirements for eligibility are general health, term birth (37 weeks or beyond), and the willingness to consume blueberry/placebo powder."
Does this research protocol include participants aged thirty and above?
"To qualify for this trial, potential participants must be between 4 and 5 months old. For minors aged 18 or younger, there are 26 studies available; additionally, 6 other trials have been designed for seniors who are 65 years of age or older."
Share this study with friends
Copy Link
Messenger